Literature DB >> 27843825

Drug adherence rate and loss to follow-up among people living with HIV/AIDS attending an ART Centre in a Tertiary Government Hospital in Western India.

Kedar G Mehta1, Rajendra Baxi2, Sangita Patel2, Mahendra Parmar3.   

Abstract

INTRODUCTION: National AIDS Control Organization (NACO) has expanded the reach of anti retroviral therapy (ART) to combat the epidemic of HIV/AIDS in India which has one of the largest populations of people living with HIV/AIDS (PLWHA) in the world. One of the major challenges related to ART is a lifelong commitment by patients to adhere diligently to daily medication dosing schedules and scheduled visits to the ART center. Hence, the current study is carried out to assess the drug adherence rate and loss to follow-up (LFU) among PLWHA attending ART centre of a tertiary care hospital in Western India.
MATERIALS AND METHODS: The current cross-sectional study was carried out using medical records of all patients registered at ART Center, Shree Sayaji General Hospital, Vadodara after taking Ethical Clearance from Local IRB. LFU was classified according to NACO guidelines. Data were collected using a standardized data extraction form as per NACO treatment card. Data entry and analysis were performed using Epi Info software.
RESULTS: Of 755 PLWHA registered at ART center, 534 (70.7%) subjects were alive on ART, 61 (8%) were transferred out, 68 (9%) died, and 92 (17%) were LFU. Nearly, 57% PLWHA have drug adherence rate of more than 95%. Education status of the participant showed independent and significant association with drug adherence.
CONCLUSION: This study showed 57.3% were adherent to ART among PLWHA, whereas 17.22% were lost to follow-up. Hence, there is a need to emphasize on increasing drug adherence rate and on outreach activities to combat LFU.

Entities:  

Keywords:  ART; drug adherence rate; loss to follow-up; people living with HIV/AIDS

Year:  2016        PMID: 27843825      PMCID: PMC5084545          DOI: 10.4103/2249-4863.192325

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

Large-scale programs to provide anti retroviral therapy (ART) have expanded to combat the epidemic of HIV/AIDS in India which is third among the populations of HIV-positive cases in the world.[1] However, the expansion ART programs have also brought challenges. One of the major challenges relates to retention of patients on ART. Successful implementation of an ART program hinges on a lifelong commitment by patients to adhere diligently to daily medication dosing schedules and scheduled visits to the ART center. A systematic review assessing the rates of follow-up in patients undergoing ART across sub-Saharan Africa reported approximately 25% of patients lost to follow-up 1 year after initiation of ART and the rate of lost to follow-up was 40% after 2 years.[2] Patients lost to follow-up (i.e. discontinuing treatment) are at high risk of more opportunistic infections, illness, and death. They also often reflect patients with advanced disease who, untreated, can further spread infection. However, despite the critical importance of lost to follow-up as a public health issue to combat the epidemic of HIV/AIDS, it is surprising that it has received very little attention.[3] There have been studies to determine the rates of follow-up and the reasons for lost to follow-up in lower income countries across the world which shows the seriousness of the issue.[34] Nevertheless, in case of India, reliable data on rates of lost to follow-up or the reasons for lost to follow-up is unavailable. Results across studies assessing the rate of follow-up in India are conflicting. The current study is carried out to study the rate of drug adherence and loss to follow-up (LFU) and factors affecting drug adherence among people living with HIV/AIDS (PLWHA) attending ART Centre of a Tertiary Care Government Hospital in Western India.

Materials and Methods

The study was carried out after taking permission from the Local Institutional Ethics Committee and Gujarat State AIDS Control Society. This cross-sectional study was carried out from August 2011 to November 2011. Shree Sayaji General Hospital (SSGH) is the largest Tertiary Care Government Hospital in Central Gujarat and third largest hospital in Western India. All PLWHA registered at ART Centre in this SSGH, from April 01, 2010, to March 31, 2011, were enrolled in the study. A retrospective chart review of all consecutive patients initiating ART at the primary ART Center in Vadodara was done. PLWHA was identified with a case or identification number only. Data from the medical chart of the patients were collected using a standardized data extraction form based on the National AIDS Control Organization (NACO) treatment card which broadly includes patient demographics, previous and current medical history, 1st day of treatment, and date of the last visit for collection of medications. As per NACO treatment card entry point has been recorded as the mechanism by which client was referred to ART center whether the client was referred from Integrated Counselling and Testing Center, Revised National Tuberculosis Control Programme/Tuberculosis, Outpatient Department of the Hospital, PPTCT, STI Clinic, outreach workers, nongovernmental organization, or by private practitioner. Data were entered and analyzed using Epi Info Software version 6.0 (Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia (USA).).[5] According to the current treatment scheme patients undergoing ART, visit the ART center once every month to collect their medication for the month. Patients not showing up at the clinic to collect their medications for three consecutive months were classified as lost to follow-up. Drug adherence among PLWHA is divided into three categories. Category A: ≥95% drug adherence missed 3 pills a month. Category B: 80–95% drug adherence where 3–11 pills missed a month and Category C: <80% drug adherence where more than 11 pills missed in a month.[6] Factors affecting drug adherence among PLWHA were studied by putting the variables in multiple logistic regression model in which P < 0.05 is considered to be statistically significant.

Results

Out of 755 PLWHA registered at ART center, 534 (70.7%) subjects were actively undergoing ART, 61 (8%) were transferred out, 68 (9%) died, and 92 (17%) were LFU. The average duration of LFU patients on ART was 2 months before they became LFU. The sociodemographic profile of 534 PLWHA actively undergoing ART is as shown in Table 1. The median age of PLWHA was 35 years, and nearly 64% were males. Nearly, 69% were married and 23% were illiterate. Majority (67%) of them were unemployed with median family income of Rs. 2000/month. Half of the PLWHA were from rural areas and a half from the urban areas.
Table 1

Sociodemographic profile of people living with HIV/AIDS attending antiretroviral treatment center

Sociodemographic profile of people living with HIV/AIDS attending antiretroviral treatment center As shown in Figure 1, the drug adherence rate among PLWHA was 306 (57.3%) PLWHA were in Category A followed by 158 (29.6%) PLWHA were in Category B while 70 (13.1%) PLWHA were in Category C.
Figure 1

Drug adherence rate among people living with HIV/AIDS attending ART center

Drug adherence rate among people living with HIV/AIDS attending ART center Table 2 shows the multivariate analysis related to factors affecting drug adherence rate among PLWHA using logistic regression model, in which address, age, employment status, entry point, marital status, place of HIV testing, and mode of transmission were not found to be associated with drug adherence. However, education status of the participant showed independent and significant association with drug adherence. Those who were literate were 1.8 times (odds ratio = 1.8, 95% confidence interval: 1.8–2.50, P < 0.05) adherent to ART as compared to illiterate.
Table 2

Multivariate analysis for factors affecting drug adherence among people living with HIV/AIDS

Multivariate analysis for factors affecting drug adherence among people living with HIV/AIDS

Discussion

Based on HIV Sentinel Surveillance 2008–2009, it is estimated that India has an adult HIV prevalence of 0.31% (0.25% among women and 0.36% among men).[7] In Gujarat, estimated HIV prevalence is 0.37% in total while 0.30% among females and 0.44% among males.[8] India's National ART Programme was launched on April 01, 2004 under the NACO, as an initiative of the Ministry of Health and Family Welfare of the Government of India and the introduction of antiretroviral therapy (ART) at free of cost at all ART centers has also been initiated. However, now, the question arises of lifelong commitment by PLWHA to adhere diligently to daily medication dosing schedules and scheduled visits to the ART center. A total of 755 patients were registered during a period of 1 year, out of which 70% were actively undergoing ART, 17% were LFU, 8% died, and 9% transferred out. Similar baseline characteristics were also observed by Sharma et al. in a Tertiary Care ART Centre in North India.[9] While a systematic review assessing the rates of follow-up in patients undergoing ART across sub-Saharan Africa also reported approximately 25% LFU within 1 year of initiation of ART.[10] In the current study, the drug adherence rate (Category A) among PLWHA attending the ART Centre of Tertiary Care Hospital in Gujarat was found to be 57.3%. Whereas Peltzer et al. in South Africa and Bijal et al. in private clinics of Mumbai found as high as 70.8% and 73% drug adherence rate, respectively.[411] However, in many studies cost has been well-documented barrier to drug adherence because of high cost of ART in private sectors giving a load to the out of pocket expenditure to PLWHA.[121314] In India, few studies have identified factors associated with adherence to ART. In this study, we have tried to find out the sociodemographic factors associated with drug adherence. Literacy status of the patient was found to be significantly associated with drug adherence with AOR of 1.8, which is comparable to studies conducted by Kleeberger et al. and Wasti et al.[1516] Contradictory to this, Sarna et al. in Pune and New Delhi; and Achappa et al. in South India found literacy significantly associated with drug adherence in bivariate analysis but not in multivariate analysis.[1718] Being a cross-sectional study, this research has its own limitations. Since, it was not our main objective, so we have tried to find relation only between drug adherence and sociodemographic characteristics, but there are many other factors associated with drug adherence which needs to be explored.

Conclusion

This study observed 57.3% drug adherence rate and 17.22% LFU among PLWHA attending ART Centre in Tertiary Care Government Hospital in Western India. As government programs in India expand access to free ART for PLWHA, the development of validated low-cost interventions that optimize adherence is quite essential now.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  14 in total

1.  ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India.

Authors:  S A Safren; N Kumarasamy; R James; S Raminani; S Solomon; Kenneth H Mayer
Journal:  AIDS Care       Date:  2005-10

2.  Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy.

Authors:  J Byakika-Tusiime; J H Oyugi; W A Tumwikirize; E T Katabira; P N Mugyenyi; D R Bangsberg
Journal:  Int J STD AIDS       Date:  2005-01       Impact factor: 1.359

3.  Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study.

Authors:  C A Kleeberger; J P Phair; S A Strathdee; R Detels; L Kingsley; L P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

4.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Authors:  Martin W G Brinkhof; François Dabis; Landon Myer; David R Bangsberg; Andrew Boulle; Denis Nash; Mauro Schechter; Christian Laurent; Olivia Keiser; Margaret May; Eduardo Sprinz; Matthias Egger; Xavier Anglaret
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

Review 5.  Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.

Authors:  Adriana Ammassari; Maria Paola Trotta; Rita Murri; Francesco Castelli; Pasquale Narciso; Pasquale Noto; Jacopo Vecchiet; Antonella D'Arminio Monforte; Albert W Wu; Andrea Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

6.  Adherence to antiretroviral therapy & its determinants amongst HIV patients in India.

Authors:  A Sarna; S Pujari; A K Sengar; R Garg; I Gupta; J van Dam
Journal:  Indian J Med Res       Date:  2008-01       Impact factor: 2.375

7.  Adherence to Antiretroviral Therapy Among People Living with HIV.

Authors:  Basavaprabhu Achappa; Deepak Madi; Unnikrishnan Bhaskaran; John T Ramapuram; Satish Rao; Soundarya Mahalingam
Journal:  N Am J Med Sci       Date:  2013-03

8.  Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study.

Authors:  Sharada P Wasti; Padam Simkhada; Julian Randall; Jennifer V Freeman; Edwin van Teijlingen
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

9.  Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

Authors:  Martin W G Brinkhof; Mar Pujades-Rodriguez; Matthias Egger
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

Review 10.  Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox; Christopher J Gill
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  6 in total

1.  Acceptability of Mobile Phone-Based Nurse-Delivered Counseling Intervention to Improve HIV Treatment Adherence and Self-Care Behaviors Among HIV-Positive Women in India.

Authors:  Mona Duggal; Venkatesan Chakrapani; Lauren Liberti; Veena Satyanarayna; Meiya Varghese; Pushpendera Singh; Mohini Ranganathan; Prabha Chandra; Nancy R Reynolds
Journal:  AIDS Patient Care STDS       Date:  2018-09       Impact factor: 5.078

2.  HIV patients retention and attrition in care and their determinants in Ethiopia: a systematic review and meta-analysis.

Authors:  Nurilign Abebe Moges; Adesina Olubukola; Okunlola Micheal; Yemane Berhane
Journal:  BMC Infect Dis       Date:  2020-06-22       Impact factor: 3.090

3.  Determinants contributing for poor adherence to antiretroviral therapy: A hospital record-based study in Balasore, Odisha.

Authors:  Mallicka Gupta; Sai Chandan Das
Journal:  J Family Med Prim Care       Date:  2019-05

4.  Loss to follow-up and associated factors among adult people living with HIV at public health facilities in Wakiso district, Uganda: a retrospective cohort study.

Authors:  Denis Opio; Fred C Semitala; Alex Kakeeto; Emmanuel Sendaula; Paul Okimat; Brenda Nakafeero; Joaniter I Nankabirwa; Charles Karamagi; Joan N Kalyango
Journal:  BMC Health Serv Res       Date:  2019-09-04       Impact factor: 2.655

5.  Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study.

Authors:  Santosh K Karade; Smita S Kulkarni; Manisha V Ghate; Ajit A Patil; Rajkumar Londhe; Sonali P Salvi; Dileep B Kadam; Rajneesh K Joshi; Bharat B Rewari; Raman R Gangakhedkar
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

6.  Methods for estimating medication adherence to antiretroviral therapy: Response to Mehta et al. (2016).

Authors:  Saurav Basu; Suneela Garg
Journal:  J Family Med Prim Care       Date:  2017 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.